Fundraising Fox
/Companies
Sign in

Achira

7 known investors

Find your way into Achira

Sign up to see every warm intro you have to Achira

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Achira team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Achira builds molecular world models that blend geometric deep learning, physics, and quantum chemistry to advance drug discovery and materials design. The company combines AI and physical simulation to enable out-of-sample prediction for biomolecular applications.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

JC
John ChoderaFounderJohn Chodera led a laboratory at Memorial Sloan Kettering Cancer Center focused on computational chemistry and drug discovery, developing statistical mechanics-based models for protein-ligand binding and free energy calculations. He now serves as President and CEO of Achira, which applies geometric deep learning and physics-based simulation to accelerate drug discovery and materials design.
TKTheofanis Karaletsos
Theofanis KaraletsosFounder

Board

ZDZavain Dar
Zavain DarFounderFounder and Managing Partner at Dimension Capital

Investors · 7

NVIDIA✓ confirmed by AchiraSanta Clara

How we know: the company's own site · thenationalherald.com · nvidia.com · Not right? Tell us

Amplify Partnerslisted by Amplify PartnersMenlo Park · $500K – $5M

How we know: Amplify Partners's portfolio page · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

DIMENSIONreportedTokyo

How we know: thenationalherald.com · Not right? Tell us

Dimension CapitalreportedSan Francisco · $1M – $10M

How we know: the VCSheet dataset · Not right? Tell us

NVenturesreportedSingapore

How we know: funding news · Not right? Tell us

Also in the syndicate · 1

Amplify

Funding

SEC filings, press & company announcements

$33M disclosed across 1 of 3 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 2

Xaira TherapeuticsXaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.
AieraAiera provides AI-enabled infrastructure that gives institutional research teams permissioned, entitlement-aware access to proprietary financial content such as broker research, expert insights, transcripts, filings, live earnings calls, and news through a single searchable environment. It is built for regulated financial environments, offering governance, transparent attribution, auditability, and integrations via enterprise APIs and MCP for AI workflows.

Companies working in the same space as Achira.

Frequently asked questions

What does Achira do?
Achira builds molecular world models that blend geometric deep learning, physics, and quantum chemistry to advance drug discovery and materials design. The company combines AI and physical simulation to enable out-of-sample prediction for biomolecular applications.
Who founded Achira?
Achira was founded by John Chodera, Theofanis Karaletsos.
Who are Achira's investors?
Achira's investors include Compound, NVIDIA, Amplify Partners, DIMENSION, Dimension Capital, NVentures.
How much funding has Achira raised?
Achira has disclosed $33M raised across 1 of its 3 known rounds.